Promising early-phase clinical research (1960s to early 1970s) suggested a therapeutic signal for serotoninergic psychedelics (e.g. psilocybin, LSD) in treating cancer-related psychiatric distress. After several decades of quiescence, research on psychedelic-assisted therapy to treat psychiatric disorders...
A new study reveals that psilocybin, found in “magic mushrooms,” induces a dynamic state of brain hyperconnectivity associated with the sensation of oceanic boundlessness and ego-altering experiences. These findings could improve the therapeutic use of psychedelics in treating mental health ...
use of LSD in psychotherapy', Jonathan Cole attends, an early ACNP president First major European conference on psychedelics; Sidney Cohen publishes positive meta-analysis on LSD safety Jonathan Cole (ACNP president 1965-66) expresses 'very mixed feelings on psychedelic research' as critical ...
Seeking Relief From Brain Injury, Some Veterans Turn to Psychedelics • Dec. 17, 2024, 4:52 AM ET (New York Times) psychedelic drug, any of the so-called mind-expanding drugs that are able to induce states of altered perception and thought, frequently with heightened awareness of sensory ...
There have been encouraging data supporting the use of psilocybin-assisted psychotherapy for depression, including previously treatment-resistant symptoms. MDMA-assisted psychotherapy is showing similar promise in treating PTSD, with excellent response and remission rates that appear durable. However, no stud...
British Columbia to find out their opinion on the potential easing of rules surrounding the medical use of psilocybin. Analysis of their answers shows that 79% of respondents consider psilocybin-assisted therapy a reasonable medical choice to treat existential distress in patients at the end of life...
Currently there is a resurgence of interest by the public, clinicians, academics, and the media in the use of psychedelics in the treatment of psychiatric disorders, or for psychospiritual purposes (Chi and Gold, 2020; Dos Santos et al., 2018; Reiff et al., 2020; Schenberg, 2018). Due...
dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JE (2018) Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Rev Clin Pharmacol 11:889–902 ...
use of psychedelics.32,33However, the incidence of adverse effects such as psychosis or HPPD in the general population is believed to be relatively low, and these effects are generally associated with the use of illicitly procured psychedelic substances, which often involves polysubstance use in ...
Psychedelics promote structural and functional neural plasticity. Cell Rep. 23, 3170–3182 (2018). Article CAS PubMed PubMed Central Google Scholar Bogenschutz, M. P. & Johnson, M. W. Classic hallucinogens in the treatment of addictions. Prog. Neuropsychopharmacol. Biol. Psychiatry 64, 250–...